GE HealthCare Expands AI-Enabled Medical Devices & Strengthens Acquisitions

As part of its AI-driven expansion, GE HealthCare has upgraded approximately 30% of its MRI scanners with AIR Recon DL, a deep-learning algorithm designed to enhance image clarity and speed.

GE HealthCare is accelerating its artificial intelligence (AI) initiatives, focusing on AI-enabled medical devices and acquisitions to strengthen its partnerships with healthcare providers. Since late 2023, the company has introduced 27 FDA-approved AI-powered medical devices, which CEO Peter Arduini described as "one of the highest in healthcare."

As part of its AI-driven expansion, GE HealthCare has upgraded approximately 30% of its MRI scanners with AIR Recon DL, a deep-learning algorithm designed to enhance image clarity and speed. Additionally, initially applied in cardiac MRI, its Sonic DL algorithm has been extended to brain and orthopedic imaging.

Strategic Acquisitions and Expanding Partnerships

The company completed two acquisitions in 2023 to bolster its AI capabilities. In April, it acquired imaging analytics and digital workflow solutions firm MIM Software for an undisclosed sum. Later in October, it purchased Intelligent Ultrasound’s clinical AI business for $51 million.

Arduini emphasized that acquisitions will remain central to GE HealthCare’s growth strategy. “M&A will play an important part of that, and we're optimistic here in 2025, and honestly into 2026, with a strong balance sheet [and] the cash flow generation that we have, that M&A can be a more healthy participation into our play,” he said.

The company has also been expanding its collaborations with health systems. In January, Sutter Health signed a seven-year, $1 billion agreement with GE HealthCare, reflecting a growing demand for integrated AI-driven solutions rather than isolated technological upgrades.

Financial Performance Reflects Growth

GE HealthCare reported strong financial results for the fourth quarter, with net earnings of $737 million, or $1.57 per share, marking an increase from $416 million, or 88 cents per share, in the same quarter last year. The company’s full-year net earnings rose to $2.1 billion, or $4.34 per share, compared to $1.6 billion, or $3.04 per share, in 2023.

Arduini indicated that the company will continue to prioritize AI investments and acquisitions to sustain its momentum in the healthcare technology sector.